References
- Mackay IR. Pathogenesis of autoimmune chronic active hepatitis. Autoimmune Liver Diseases, L. Krawitt, R. Wiesner. Raven Press, New York 1991; 21–42
- Closs O, Haukenes G, Blomhoff JP, Gjone E. High titres of antibodies against rubella and morbilli virus in patients with chronic hepatitis. Scand J Gastroenterol 1973; 8: 523–528
- Zauli D, Crespi C, Bianchi FB, Craxi A, Pisi E. Autoimmunity chronic liver disease caused by hepatitis delta virus. J Clin Pathol 1986; 39: 897–899
- Vento S, Garofano T, Di Pierri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991; 337: 1183–1187
- Roget M, Buti M, Esteban JI, Esteban R, Guardia J. The presence of anti-HCV antibodies in the serum of patients with chronic active hepatitis and antinuclear antibodies. Hepatology 1990; 11: 333–335
- Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 3: 258–259
- Renault PF, Hoofnagle JH. Side effects of alpha interferon. Sem Liv Dis. 1989; 9: 273–277
- Paradis K, Dib A, Homberg JC, Bernard O, Alagille D, Alvarez F. Detection of antiendoplasmic reticulum antibody positive autoimmune hepatitis in children using an ELISA technique. J Pediatr Gastroenterol Nutr 1988; 7: 816–822
- Wachter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer Zum, Buschenfelde K-H, Manns M. Characterization of liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol 1990; 11: 232–239
- Graham J. Isolation of subcellular organelles and membranes. Centrifugation: a practical approach, D Rickwood. Information Retrieval Limited, London 1978; 136–146
- Touster O, Aronson NN, Dulaney JT, Hendrickson H. Isolation of rat liver plasma membranes. Use of nucleotide pyrophosphatase and phosphodiesterase I as a marker enzymes. J Cell Biol 1970; 47: 604–618
- Lowry D, Rosenbrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. Biol Chem 1959; 193: 265–275
- Heusser CH, Stocker JW, Gisler RH. Methods for binding cells to plastic. Application to solid-phase immunoassays for cell surface antigens. Methods Enzymol 1981; 73B: 406–418
- Morris RE, Horowitz DA. Cellular enzyme-linked immuno-specific assay (C ELISA). IV Inhibition of endogenous cellular alkaline phosphatase activity. J Immunol Methods 1984; 68: 11–17
- Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Alvarez F, Bernard O, Homberg JC, Kreibich G. Anti liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med 1985; 161: 1231–1236
- Gueguen M, Meunier-Rotival M, Bernard O, Alvarez F. Anti-liver-kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily. J Exp Med 1988; 168: 801–806
- Abuaf N, Johanet C, Homberg JC. Autoantibodies in autoimmune chronic active hepatitis. Autoimmune Liver Diseases, L. Krawitt, R. Wiesner. Raven Press, New York 1991; 93–109
- Maggiore G, Bernard O, Hadchouel M, Hadchouel P, Odievre M, Alagille D. Treatment of autoimmune chronic hepatitis in childhood. J Pediatr 1984; 104: 839–844
- Odievre M, Maggiore G, Homberg JC, Saadoun F, Cour-Ouce AM, Yvart J. Seroimmunologic classification of chronic hepatitis in 57 children. Hepatology 1983; 3: 407–409
- Martini E, Abuaf F, Cavalli F, Durand V, Johanet C, Homberg JC. Antibody to liver cytosol (Anti-LCI) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988; 8: 1662–1666
- Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer Zum, Buschenfelde K-H. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987; i: 292–294
- Codoner-Franch P, Paradis K, Gueguen M, Bernard O, Amar Costesec A, Alvarez F. A new antigen recognized by anti-liver-kidney microsome antibody (LKMA). Clin Exp Immunol 1989; 75: 354–358
- Manns MP, Griffin J, Sullivan KF, Johnson EF. LKM1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P450 monooxygenase. J Clin Invest 1991; 88: 1370–1378
- Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takayashi K. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990; 336: 1400–1403
- Lenzi M, Johnson PJ, Mc Farlane IG, Ballardini G, Smith HM, MC Farlane BM. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338: 277–280
- Alvarez F, Martres P, Maggiore G, Bernard O, Dussaix E. False-positive result of hepatitis C enzyme-linked immunosorbent assay in children with autoimmune hepatitis. J Pediatr 1991; 119: 75–77
- Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Coz YL. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992; 16: 630–636
- Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992; 103: 1290–1295
- Greeve M, Ferrell L, Kim M, Combs C, Roberts J, Ascher N, Wright TL. Cirrhosis of undefined pathogenesis: Absence of evidence for unknown viruses or autoimmune process. Hepatology 1993; 17: 593–598